REGN vs RIG · P/E 14, rev $14.34B vs rev $3.52B
Regeneron Pharmaceuticals Inc (REGN) versus Transocean Ltd (RIG) — a side-by-side from cached financials, not a winner call.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Transocean Ltd (RIG) is a oil & gas drilling company listed on NYSE.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Latest reported RIG revenue for 2024-12-31 was $3.52B. Net income was -$512.0M. Revenue was up 24.4% from 2023-12-31 to 2024-12-31. RIG currently screens at market cap $6.18B.
REGN currently screens at market cap $59.10B and trailing P/E 13.9. RIG currently screens at market cap $6.18B.
Not investment advice. Open the REGN and RIG stock pages for the full models.
Not investment advice.